drugset / Trial / NCT01719757
PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain
NaSingle-groupOpen-labelTreatment
Summary
The aim of the study is to evaluate the efficacy of TARGIN administration as an analgesic to Korean patients treated with opioid analgesics for moderate-to-severe cancer pain under conditions of daily practice.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-10
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naloxone | Small molecule | 5 mg | Oral |
| Subject | Naloxone | Small molecule | 10 mg | Oral |
| Subject | Oxycodone | Other / unclassified | 10 mg | Oral |
| Subject | Oxycodone | Other / unclassified | 20 mg | Oral |